Background and objectives: Single gene mutations are increasingly recognized as causes
of cerebral palsy (CP) phenotypes, yet there is currently no standardized framework for …

Cerebral palsy (CP) is the most common cause of childhood physical disability, with
incidence between 1/500 and 1/700 births in the developed world. Despite increasing …

Aim To conduct a systematic review of phenotypic definition and case ascertainment in
published genetic studies of cerebral palsy (CP) to inform guidelines for the reporting of …

ABSTRACT AIM To identify clinical characteristics that are associated with genetic cerebral
palsy (CP) to aid clinicians in selecting candidates for genetic testing. METHODS The …

Cohort-based whole exome and whole genome sequencing and copy number variant
(CNV) studies have identified genetic etiologies for a sizable proportion of patients with …

AIM To determine which patients with cerebral palsy (CP) should undergo genetic testing,
we compared the rate of likely causative genetic variants from whole‐exome sequencing in …

Cerebral palsy is a clinical descriptor covering a diverse group of permanent, non-
degenerative disorders of motor function. Around one-third of cases have now been shown …

Importance There are many known acquired risk factors for cerebral palsy (CP), but in some
cases, CP is evident without risk factors (cryptogenic CP). Early CP cohort studies report a …

Cerebral palsy (CP) is a broad clinical descriptor that encompasses a heterogeneous group
of nonprogressive neurodevelopmental disabilities affecting movement and posture. While …

AIM: To determine which cerebral palsy (CP) patients should undergo genetic testing, we
compared the rate of likely causative genetic variants from whole exome sequencing (WES) …